Brazil vs Egypt: Population requiring preventive chemotherapy for schistosomiasis
Brazil
2.21 million
in 2024
Egypt
2.98 million
in 2023
Brazil rank
29th
Egypt rank
26th
Population requiring preventive chemotherapy for schistosomiasis over time
- Brazil
- Egypt
How they compare
Egypt currently reports 2.98 million against 2.21 million in Brazil, a difference of 766,860.
That makes Egypt's figure about 1.3 times Brazil's.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Brazil ahead.
Brazil ranks 29th and Egypt ranks 26th of 52 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.52 million | 1.76 million | 247,520 | Egypt |
| 2020s | 2.19 million | 2.94 million | 751,028 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Brazil or Egypt?
- Egypt, at 2.98 million against 2.21 million in Brazil as of 2023.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Brazil and Egypt?
- 766,860, with Egypt ahead.
- How many years of comparable data are there for Brazil and Egypt?
- 14 years are reported by both, from 2010 to 2023.
- How do Brazil and Egypt rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Brazil ranks 29th and Egypt ranks 26th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.